America in Transition Pages

Saturday, October 24, 2015

FDA Advisory Panel Favors New Gout Treatment in 10-4 Vote

(MedPage Today) -- Panel backs AstraZeneca's lesinurad, with caveats on safety

from MedPage Today Washington Watch http://ift.tt/1PIE3Rj
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)